The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Clinical trial NCT06773221 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06773221
Sponsor: Beijing Friendship Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Metabolic Dysfunction Associated Fatty Liver Disease Compensated Liver Cirrhosis

Start date: 2025-02-05
Primary completion: 2028-01-31
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.